MBA in Biotech Management

The Geneva Business School launches next fall a MBA in Biotech Management at Campus Biotech Geneva. This MBA equips students with both scientific fluency and strategic business acumen.

In a rapidly evolving industry where scientific breakthroughs must translate into real-world impact, the need for visionary leadership has never been greater. The MBA in Biotech Management, offered by GBS Geneva Business School, is designed to bridge the gap between science and business — empowering professionals to lead innovation in biotechnology, pharma, and life sciences. The curriculum is structured across two semesters and combines core business disciplines with industry-specific expertise in biotech management.

The programme focuses on key areas such as:

• Biotech Commercial Strategy & Sales Execution
• Regulatory, Market Access & Quality Assurance
• Entrepreneurship & Strategy in Biotech
• Financial & Operations Management in Life Sciences
• Leadership, People & Culture in Biotech

These courses are paired with practical modules on artificial intelligence in biotech, biotech applications like RNA and immunotechnology, and ethics, compliance, and ESG standards.

Students can tailor their experience with electives like:

• Venture Capital & Fundraising
• Public-Private Partnerships
• Technology Transfer & Innovation
• Change Management & Deeptech
• Project Management & Disruptive Innovation

This programme wants to become  a launchpad for future executives, founders, and innovators in health and science. With strong industry alignment and a focus on transformation, it nurtures the leadership needed to bring biotech advances from lab bench to global market.

As MBA Director Francesco Derchi puts it:

“The future of biotech lies not just in scientific discovery, but in visionary leadership that bridges the gap between innovation and impact.”

➡️ More Information: Geneva Business School 
⏰ Application deadline: mid-August